Standard InChI: InChI=1S/C18H23FO2/c1-18-7-6-13-12-5-3-11(20)8-10(12)2-4-14(13)15(18)9-16(19)17(18)21/h3,5,8,13-17,20-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1
Standard InChI Key: KDLLNMRYZGUVMA-ZXXIGWHRSA-N
Associated Targets(Human)
Testis-specific androgen-binding protein 320 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Estrogen receptor alpha 17718 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Estrogen receptor beta 9272 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Estrogen receptor 3070 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Estrogen receptor 1901 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Androgen Receptor 5522 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Alpha-fetoglobulin 20 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Estrogen receptor 2172 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: Yes
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: Yes
Availability: Yes
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 290.38
Molecular Weight (Monoisotopic): 290.1682
AlogP: 3.56
#Rotatable Bonds: 0
Polar Surface Area: 40.46
Molecular Species: NEUTRAL
HBA: 2
HBD: 2
#RO5 Violations: 0
HBA (Lipinski): 2
HBD (Lipinski): 2
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.33
CX Basic pKa:
CX LogP: 3.56
CX LogD: 3.56
Aromatic Rings: 1
Heavy Atoms: 21
QED Weighted: 0.77
Np Likeness Score: 1.91
References
1.Levesque C, Merand Y, Dufour JM, Labrie C, Labrie F.. (1991) Synthesis and biological activity of new halo-steroidal antiestrogens., 34 (5):[PMID:2033587][10.1021/jm00109a014]
2.Liu A, Carlson KE, Katzenellenbogen JA.. (1992) Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography., 35 (11):[PMID:1597861][10.1021/jm00089a024]
3.Pomper MG, VanBrocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ, Katzenellenbogen JA.. (1990) 11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity., 33 (12):[PMID:1701833][10.1021/jm00174a009]
4.Hanson RN, Napolitano E, Fiaschi R.. (1990) Synthesis and estrogen receptor binding of novel 11 beta-substituted estra-1,3,5(10)-triene-3,17 beta-diols., 33 (12):[PMID:2258901][10.1021/jm00174a010]
5.Yoo J, Dence CS, Sharp TL, Katzenellenbogen JA, Welch MJ.. (2005) Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol., 48 (20):[PMID:16190762][10.1021/jm050121f]